Lisa Ellen Porter

CIK 1940462 · View on SEC EDGAR ↗

Insider

First SEC filing: Aug. 31, 2022 · Latest: Aug. 31, 2022

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 2 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
July 28, 2026 VANI A 40,000 40,000 Direct Acquired (price as of 2026-08-21)
July 28, 2026 VANI A 80,000 80,000 Direct Acquired (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
July 28, 2026 VANI RSUs Common Stock (40,000) 40,000 Acquired
July 28, 2026 VANI Common Stock Option Common Stock (80,000) $1.31 July 27, 2036 80,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Aug. 31, 2022 VANI Common Stock 0 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

VANI

Chief Medical Officer
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2024 $480,000 $67,600 $116,800 $13,800 $678,200
2023 $468,933 $55,800 $123,600 $13,200 $661,533

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.